RespireRx Pharmaceuticals Inc

RSPID:OTCPK
RT Quote | Exchange | USD
Last | 01/22/21 EST
0.032quote price arrow down-0.001 (-3.0303%)
Volume
491,927
52 week range
0.01 - 1.50

...

Loading . . .

KEY STATS

  • Open0.033
  • Day High0.036
  • Day Low0.0313
  • Prev Close0.033
  • 52 Week High1.50
  • 52 Week High Date03/02/20
  • 52 Week Low0.01
  • 52 Week Low Date01/06/21
  • Market Cap2.07M
  • Shares Out64.56M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.24
  • 1 Year % Change-96.8

RATIOS/PROFITABILITY

  • EPS (TTM)-3.12
  • P/E (TTM)-0.01
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-2.86M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-22.57%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest RespireRx Pharmaceuticals Inc News

There is no recent news for this security.

Latest RSPID News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
RespireRx Pharmaceuticals Inc., formerly Cortex Pharmaceuticals, Inc., is engaged in the discovery, development and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. The Company is focused on the clinical development in the areas of respiratory disorders, including respiratory depression and sleep apnea. It is engaged in research and clinical development of a class of compounds referred to as ampakines, which act to enhance the...
Arnold Lippa Ph.D.
Chairman
Timothy Jones
President
Jeff Margolis
Chief Financial Officer
Address
126 Valley Rd Ste C
Glen Rock, NJ
07452-1796
United States